Investor's Business Daily on MSN4h
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs ShortageHims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers ... for Safe Medicines said the 1-minute ad is "misleading in ...
During Sunday’s Super Bowl, Hims & Hers Health ... to life-saving weight loss treatments.” The ad is just the latest flashpoint in a battle over compounded GLP-1 drugs.
That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss ... of these medications, known as compounded ...
Hims has accelerated its impressive growth from 46% two quarters ago to 77% now. Forward guidance is at an even stronger 90%, which is largely due to growth in GLP-1’s for their weight loss ...
Cleverly targeting the high-demand, weight-loss drug segment, the company dramatically pushed its obesity offerings in a cutting-edge, one-minute spot. It's important to note here that Hims & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback